News

Deal Announcements

Lycera Secures Venture Capital Debt

Tuesday, April 8, 2014 5:54:00 AM PDT | VentureDeal
   Ann Arbor, MI  --  Pharmaceuticals company Lycera has garnered $4 million in new venture capital debt investment.

Lycera is developing proprietary small molecule treatments for immune disorders.

Investors in the financing were not disclosed.

Lycera is still seeking almost $5.2 million in additional financing, according to the SEC regulatory filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1